The University of Chicago Header Logo

Connection

Mark Kozloff to TNF-Related Apoptosis-Inducing Ligand

This is a "connection" page, showing publications Mark Kozloff has written about TNF-Related Apoptosis-Inducing Ligand.
  1. A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2013 Dec; 12(4):248-54.
    View in: PubMed
    Score: 0.455
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.